cycloheximide has been researched along with HPV Infection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, PK; Chen, GG; Du, J; Tsang, RK; van Hasselt, CA; Vlantis, AC | 1 |
de Jong, S; de Vries, EG; Hougardy, BM; Timmer, T; van den Heuvel, FA; van der Zee, AG | 1 |
2 other study(ies) available for cycloheximide and HPV Infection
Article | Year |
---|---|
Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression.
Topics: Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Blotting, Western; Caspase 3; Caspase 8; Caspases; Cell Line, Tumor; Cycloheximide; Humans; Laryngeal Neoplasms; Membrane Proteins; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Transfection; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2004 |
Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase 8; Caspases; Cell Line, Tumor; Cisplatin; Combined Modality Therapy; Cycloheximide; Enzyme Activation; fas Receptor; Female; Flow Cytometry; HeLa Cells; Humans; Interferon-alpha; Interferon-gamma; Papillomaviridae; Papillomavirus Infections; Recombinant Proteins; Sensitivity and Specificity; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2005 |